Good for gaining CRO experience, but currently falling apart - Site Contract Leader Parexel Employee Review

2.0
20 Jun 2026
Recommend
CEO approval
Business outlook

Pros

It was a great company to enter the CRO industry. Remote work Private health-care Businesses phone

Cons

​Over the last couple of years, the company has really started to go downhill. Wage increases were postponed until July, bonuses have never even existed, and the real revenue-generators are completely undervalued. Meanwhile, middle management is bloated with people who bring zero value to the team. ​Massive layoffs have started, which has created a lot of job insecurity. While downsizing might be necessary, I just hope they actually target the dead weight. Additionally, management is heavily shifting focus toward offshoring to India; in my experience, the collaboration was difficult as the output from those teams was often very limited and lacked creativity. ​Work-life balance is nonexistent. I was consistently doing the workload of 2+ FTE with absolutely no financial reward or incentive. Upper management is completely disconnected from reality, burdening teams with useless, time-wasting procedures just so they can pretend to be "innovative." All in all - way too much work for peanuts.

Explore other reviews about Parexel

5.0
16 Jun 2026
Recommend
CEO approval
Business outlook

Pros

Well trained managers that empower you, truly listen to you, and only do well if YOU do well/ they provide resources and definitely offer development opportunities to those who want them AND have demonstrated they can maintain their scoped, regular duties at a high level of quality while working on special development projects Also unlimited RTO in US

Cons

no bonuses and too much focus/emphasis on how many years with *Parexel*, as opposed to how many years total you have been in the industry (ex doing site management at another CRO or Sponsor group )

1.0
25 Jun 2026
Recommend
CEO approval
Business outlook

Pros

The only pro is that they offer remote work.

Cons

I would give zero stars if I could, but since I can’t, I’m forced to give one. They seem to have layoffs almost every year. Their US-based pharmacovigilance team was also affected in 2024 and 2025. It really feels like a hire-and-fire culture.

See reviews by: Helpful|Rating|Date|All